New ultrasound device could replace MRI for liver fat measurement
NCT ID NCT07321925
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing a new Thermoacoustic Enhanced Ultrasound device to measure fat in the liver. Researchers will compare the device's readings to the gold-standard MRI measurement in 49 adults with fatty liver disease. The goal is to develop a more accessible and affordable tool for assessing liver fat, which is a key indicator of metabolic health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Thermoacoustic Enhanced Ultrasound device
- What this could lead to
- If successful, this could lead to a cheaper, more accessible way to measure liver fat without an MRI, helping diagnose fatty liver disease earlier.
- What could go wrong
- This is a small pilot study with only 49 participants. The new device may not match MRI accuracy, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATTY LIVER DISEASE, NONALCOHOLIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ENDRA Life Sciences
RECRUITINGAnn Arbor, Michigan, 48105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Weight-Loss surgery rewire the Liver's energy engine?
- Could a new drug tame fatty liver disease? early trial aims to find out
- Liver scan changes may foretell deadly complications
- Could a weekly shot help more people donate part of their liver?
- Experimental drug aims to reverse liver scarring in MASH cirrhosis
- Experimental drug aims to stop liver failure in MASH cirrhosis